Darnytsia (company) explained

Darnytsia
Trade Name:Darnytsia
Native Name:Дарниця
Native Name Lang:uk
Type:Private
Industry:Pharmaceutical industry
Predecessor:
Hq Location City:Kyiv
Hq Location Country:Ukraine
Key People:
Revenue:US$100 million
Revenue Year:2020
Num Employees:1,100[1]
Num Employees Year:2020

Darnytsia (Ukrainian: Дарниця) is a Ukrainian pharmaceutical company.

History

In 1930, the Kyiv branch of the Ukrainian Institute of Experimental Endocrinology was established, which produced the first drugs in 1932. In particular, hematogen (liquid and tablets). In 1938, new production buildings were put into operation, and by 1940, the production capacity amounted to 4 million units of products, in monetary terms being about 5 million roubles.[2] [3]

During the Second World War, Darnytsia was evacuated to the Urals. In 1950, the Kyiv enterprise was practically restored, and by 1952, the capacity was brought to 15.19 million units of production. In 1954, the branch of the institute was reorganized into the Darnytsia Chemical and Pharmaceutical Plant. At first, it specialized in the production of solutions for injection in ampoules. In the 1960s, a glass-blowing manufacturing facility with a capacity of 300 million ampoules was put into operation.[2]

In 1976, the Kyiv industrial chemical and pharmaceutical association Darnytsia was established. The products of the combined enterprise were exported to 37 countries of the world.[4] In 1985, the Monastyryshchenskyi Chemical and Pharmaceutical Plant was added to this association.[2]

In 1993, Darnytsia was transformed into a collective enterprise.[5] In 1994, the company became a closed joint stock company (CJSC), and since 2012, it has been a private joint stock company (PrJSC).[6]

In the 1990s, Darnytsia began to re-equip production in accordance with the requirements of the GMP (Good Manufacturing Practice) standard.[7] By 2010, according to a study by O. Posylkina and M. Sidorenko, the company was ahead of other Ukrainian enterprises, having certified 5 sites where 112 different drugs were produced.[8]

During the same period, the main production was modernized. In 1997, the reconstruction of the area for aseptic preparation and bottling of medicines was completed. In 2000, the system for obtaining drinking-quality water was reconstructed, in 2002, a new plant of sterile cephalosporin antibiotics was launched, in 2012, the ampoule production was re-equipped.[9]

In the early 2000s, Darnytsia and four other largest enterprises in Ukraine occupied 21% of the Ukrainian market in monetary terms and 32% in physical terms. Those manufacturers provided more than half of all types of medicines produced by the entire Ukrainian pharmaceutical industry (65 factories, 27 pharmaceutical plants, 119 small enterprises and separate workshops).[10]

In 2008, with the help of the German company Schäfer, a logistics complex with a total area of 15 thousand square meters was launched, where there is a robotic high-rise warehouse (32 meters) for 10 thousand pallet places.[11] [12]

According to research by Mykola Grebnev and Inna Vinnikova, by 2009 the company had a production area of more than 30 thousand square meters. The production capacity made it possible to produce over 500 million ampoules, 4 billion tablets, 10 million tubes of soft dosage forms, 30 million vials of sterile antibiotics and 35 million drop vials. According to various estimates, the company's share in the Ukrainian pharmaceutical market was about 7%.[13]

In 2014, the company's net income amounted to ₴1.2 billion. This was the third place among the Ukrainian pharmaceutical manufacturers. In 2015, Darnytsia also ranked third in terms of sales in pharmacies (among 620 Ukrainian and 1,561 foreign participants).[14]

In 2016, Darnytsia was included into the Top 20 most innovative companies in Ukraine by Forbes Ukraine.[15] [16] The company has implemented an ERP system that allows it to control logistics, plan sales and focus a specific production for a specific demand.[17]

In 2019, the company was rebranded.[18]

Social responsibility and charity

According to Natalia Tkachenko, in 2012, Darnytsia was among the top three companies in terms of disclosure of information on corporate social responsibility (among the 20 largest pharmaceutical manufacturers in Ukraine).[19] [20]

Olga Rogulya gives a number of figures for 2019. Among the philanthropic projects, university scholarships were funded for ₴3.4 million, a study of public issues and educational activities of The Aspen Institute Kyiv was funded for ₴1 million, as well as scholarships for participants in the Petro Jacyk International Competition for Experts in the Ukrainian Language.[21]

Assistance to charitable foundations amounted to ₴23.3 million. Social programs and projects were funded, in particular, "З турботою про співвітчизника" ("Taking care of a compatriot"), #GivingTuesday, "Твій безмежний світ" ("Your boundless world").[22]

External links

Notes and References

  1. Web site: 50 найкращих роботодавців . 4 January 2021 . Forbes Ukraine . 12 August 2021 . https://web.archive.org/web/20210428083449/https://forbes.ua/ratings/50-naykrashchikh-robotodavtsiv-04012021-826 . 28 April 2021 . uk . 50 best employers.
  2. Web site: Дарниця Фармацевтична фірма . Шквир О.М. . 2007 . . 12 August 2021 . https://web.archive.org/web/20210513084801/http://esu.com.ua/search_articles.php?id=23655 . 13 May 2021 . uk . Pharmaceutical company Darnitsa.
  3. Ілляшенко . І.О. . April 2016 . Історія розвитку та сучасний стан медичної промисловості Києва . History of development and current state of the medical industry in Kyiv . 12 August 2021 . uk . Глобальні та національні проблеми економіки . 10 . https://web.archive.org/web/20210602215855/http://www.global-national.in.ua/archive/10-2016/123.pdf . 2 June 2021.
  4. Карпенко . І.В. . 1980 . . М.П. . Київське виробниче хіміко-фармацевтичне об'єднання "Дарниця" . Kyiv Production Chemical and Pharmaceutical Association "Darnytsia" . 12 August 2021 . uk . . 5 . 138 . https://web.archive.org/web/20210515195911/http://irbis-nbuv.gov.ua/E_LIB/PDF/ukr0000940_1.pdf . 15 May 2021.
  5. Web site: Семейный рецепт: что спасло фармкомпанию "Дарница". Екатерина Гребеник . 25 September 2015. Forbes Ukraine. 19 August 2021. https://web.archive.org/web/20151004010410/http://forbes.net.ua/magazine/forbes/1401481-semejnyj-recept-chto-spaslo-farmkompaniyu-darnica. 4 October 2015. ru . A family recipe: What saved the pharmaceutical company "Darnitsa".
  6. Web site: "Дарница" фармацевтическая фирма . 29 November 2016 . LB.ua . 12 August 2021 . https://web.archive.org/web/20210329143804/https://lb.ua/file/company/3580_darnitsa_farmatsevticheskaya_firma_.html . 29 March 2021 . ru . "Darnitsa" pharmaceutical company.
  7. Web site: Дело Марцинчиков, или как родились киевские фармгиганты . Елена Жога . 28 January 2021 . ThePharma.Media . 12 August 2021 . https://web.archive.org/web/20210227000733/https://pharma.net.ua/publications/articles/24923-delo-marcinchikov-ili-kak-rodilis-kievskie-farmgiganty . 27 February 2021 . ru . The Marcinchikovs case, or how the Kyiv pharma giants were born.
  8. Посилкіна . О.В. . Сидоренко . М.І. . 2010 . Актуальні аспекти управління якістю наукової діяльності у фармацевтичній галузі . Actual aspects of quality management of scientific activity in the pharmaceutical field . 12 August 2021 . uk . . Вісник Національного університету "Львівська політехніка" . 684 . 30 . https://web.archive.org/web/20210602220127/http://ena.lp.edu.ua/bitstream/ntb/18761/1/8-29-33.pdf . 2 June 2021.
  9. Web site: Фармацевтическая компания Дарница . 30 July 2019 . Liga.net . 12 August 2021 . https://web.archive.org/web/20210628153531/https://file.liga.net/companies/darnica . 28 June 2021 . ru . Pharmaceutical company Darnitsa.
  10. Мороз . Л.А. . Савченко . Ю.Т. . 2002 . Маркетингові стратегії вітчизняних виробників на фармацевтичному ринку України . Marketing strategies of domestic manufacturers in the pharmaceutical market of Ukraine . 12 August 2021 . uk . . Вісник Національного університету "Львівська політехніка" . 446.
  11. Web site: Строгий режим: как работает завод "Дарницы" во время карантина . 2020 . РБК-Україна . 12 August 2021 . https://web.archive.org/web/20210602220105/https://www.rbc.ua/static/longread/darnica/index.html . 2 June 2021 . ru . Strict regime: how the Darnitsa plant works during quarantine.
  12. Web site: Фармацевтическая компания "Дарница" — производитель европейского уровня . Галина Галковская . 30 September 2013 . Apteka (Pharmacy) newspaper . 12 August 2021 . https://web.archive.org/web/20210603074425/https://www.apteka.ua/article/254227 . 3 June 2021 . ru . Pharmaceutical company "Darnitsa" is a European-level manufacturer.
  13. Гребньов . Микола . Віннікова . Інна . 2009 . Управління якістю — як важливий чинник конкурентоспроможності на фармринку . Quality management — as an important factor of competitiveness in the pharmaceutical market . 12 August 2021 . uk . Маркетинг в Україні . 2 . 60–63 . 1606-3732 . https://web.archive.org/web/20200922014333/https://ir.kneu.edu.ua/handle/2010/4360?show=full . 22 September 2020.
  14. 2 April 2016 . ТОП-100 медицинских компаний Украины . TOP-100 medical companies in Ukraine . 12 August 2021 . ru . Kyiv . . Рейтинги крупнейших . 2 . 66–69 . https://web.archive.org/web/20170318013720/https://issuu.com/zoloyedov/docs/top-100_magazine._pharmacology_comp . 18 March 2017.
  15. Web site: Как национальные производители отвоевывают украинский фармрынок . Иван Скавронский . 26 July 2016 . . 12 August 2021 . https://web.archive.org/web/20210602214751/https://delo.ua/business/kak-nacionalnye-proizvoditeli-otvoevyvajut-ukrainskij-farmrynok-320460/ . 2 June 2021 . ru . How national manufacturers are conquering the Ukrainian pharmaceutical market.
  16. Швиданенко . Г.О. . Бойченко . К.С. . 2017 . Інноваційна модель розвитку бізнесу в Україні . Innovative model of business development in Ukraine . 12 August 2021 . uk . . . Вісник Хмельницького національного університету . 4 . 195 . https://web.archive.org/web/20210602220514/https://ir.kneu.edu.ua/bitstream/handle/2010/27217/Vchnu_38.pdf . 2 June 2021.
  17. Web site: Спасти будущее: первый рейтинг инновационных компаний Украины . Роман Корнилюк, Павел Харламов, Евгений Шишацкий . 25 May 2016 . Forbes Ukraine . https://web.archive.org/web/20161126090420/https://forbes.net.ua/magazine/forbes/1416757-spasti-budushchee-pervyj-rejting-innovacionnyh-kompanij-ukrainy . 26 November 2016 . ru . To save the future: the first rating of innovative companies in Ukraine.
  18. Web site: ТОП-25 украинских брендов . 24 February 2020 . . 12 August 2021 . https://web.archive.org/web/20210604014556/https://www.dsnews.ua/economics/top-25-ukrainskih-brendov-24022020230000 . 4 June 2021 . ru . TOP-25 Ukrainian brands.
  19. Ткаченко . Н.О. . Червоненко . Н.М. . Книш . Є.Г. . 2013 . Сучасний стан і характеристика соціальної відповіднальності підприємницької діяльності . Current state and characteristics of social responsibility of entrepreneurial activity . 12 August 2021 . uk . . . Запорожский медицинский журнал . 2 . 77 . 80 . 2519-8807 . https://web.archive.org/web/20210602214231/http://dspace.zsmu.edu.ua/bitstream/123456789/790/1/ZMJ_1302_076-082.pdf . 2 June 2021.
  20. Ткаченко . Н.О. . 2020 . Дослідження стану та напрямів соціальної активності суб'єктів фармацевтичного підприємництва . Research of the state and directions of social activity of the subjects of pharmaceutical business . 12 August 2021 . uk . . . Management, Economy and Quality Assurance in Pharmacy . 3 . 63 . 51 . 2519-8807 . https://web.archive.org/web/20210602220128/http://dspace.zsmu.edu.ua/bitstream/123456789/11928/1/207862-477460-1-PB.pdf . 2 June 2021.
  21. Book: 978-1-4879-3791-1. Рогуля О.Ю.. Vancouver. 744–746. Соціальні аспекти конкурентоспроможності фармацевтичних підприємств. 2020. https://web.archive.org/web/20210602214821/http://dspace.uccu.org.ua/bitstream/123456789/8386/1/DYNAMICS-OF-THE-DEVELOPMENT-OF-WORLD-SCIENCE_15-17.04.2020.pdf. 2021-06-02. Perfect Publishing. The 8th International scientific and practical conference "Dynamics of the development of world science" (April 15-17, 2020).
  22. Рогуля . О.Ю. . 2020 . Соціальні аспекти конкурентоспроможності фармацевтичних підприємств . Social aspects of the competitiveness of pharmaceutical enterprises . 12 August 2021 . uk . Vancouver . Perfect Publishing . The 8th International Scientific and Practical Conference "Dynamics of the Development of World Science" (April 15–17, 2020) . 744–746 . 978-1-4879-3791-1 . https://web.archive.org/web/20210602214821/http://dspace.uccu.org.ua/bitstream/123456789/8386/1/DYNAMICS-OF-THE-DEVELOPMENT-OF-WORLD-SCIENCE_15-17.04.2020.pdf . 2 June 2021.